| RESEARCH ARTICLE |
|
| Year : 2009 | Volume
: 30
| Issue : 1 | Page : 42-46 |
|
|
A study on Shvasahara Karma of Tamalaki (Phyllanthus fraternus Webster)
Binay Sen1, SD Dubey2, VP Singh3, K Tripathi4
1 Ph.D. Scholar, Department of Dravyaguna, Institute of Medical Sciences, Banaras Hindu University, Varanasi- 5 (U. P.), India
2 Professor, Department of Dravyaguna, Institute of Medical Sciences, Banaras Hindu University, Varanasi- 5 (U. P.), India
3 Professor, Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi- 5 (U. P.), India
4 Professor, Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi- 5 (U. P.), India
Correspondence Address:
Binay Sen
Ph.D. Scholar, Department of Dravyaguna, Institute of Medical Sciences, Banaras Hindu University, Varanasi- 5 (U. P.)
India
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
Tamakashvasa as described in Ayurveda is a disease of Pranavaha Srotas (Respiratory system) involving multiple etiopathogenesis. The clinical features are nearly similar to that of Bronchial asthma described in Modern medicine. This study was designed to explore the therapeutic effect and synergistic action (if any) of a plant Tamalaki (Phyllanthus fraternus Webster). Tsmalaki is included in Shvasahara and Kasahara groups, used in many formulations prescribed in Shvasaroga in Ayurveda. Research works suggest its antihistaminic property in experimental model and effective in non bacterial upper respiratory disorders. The present study comprises 3 groups (each 10 patients). Group A was treated with trial drug Ghanasattva of P. fraternus Webster, 500mg, thrice daily, orally; while Group B was treated with modern standard drugs (a) Tab. Theo-asthalin, thrice daily, orally and (b) Asthalin inhaler, SOS and Group C as combination of both therapies. Total duration of treatment was 45 days. The observations reveal that, Group A has much better improvement in increasing Jaranashakti (t=7.57; p<0.001) and Ruchi (t=9.86; p<0.001) in comparison to Group B and Group C. Moreover, Group C was found more effective in reducing majority of sign-symptoms as such Breathlessness (t=9.00; p<0.001), Cough (t=6.47; p<0.001), Expectoration (t=9.00; p<0.001) Wheezing (t=7.96; p<0.001), Rhonchi (t=7.96; p<0.001), Jaranashakti (t=4.71; p<0.01) and Ruchi (t=6.68; p<0.001). |
|
|
|
| [PDF]* |
|
 |
|
